Table 1 List of previously reported cancer biomarker candidates with sex disparity identified by a PubMed search
Symbol | Gene name | Sex-biased function in cancer | References |
---|---|---|---|
- Regulation of cell cycle, cellular differentiation, and DNA damage | Li |
||
- More frequent mutation in female-derived HCC | |||
- Regulation of tumor cell death | Salehi |
||
- Higher levels of expression specific in female | |||
- Regulation of cell growth and adhesion between cells | Xia |
||
- More frequent mutation in male liver cancer patients | |||
- Regulation of apoptosis and cell cycle | Li |
||
- Significantly expressed higher in female HCC | |||
- Regulation of cell growth and chemokine secretion | Li |
||
- Lower expressed specific in male thyroid cancer patients | |||
- Protection of normal cells against damage induced by carcinogens in HCC | Niu |
||
- Significantly associated with overall survival in HCC patients | |||
- Strong correlation between inflammation and cancer | Naugler |
||
- Low expression reduced risk of cancer in female liver cancer patients | |||
- Suppression of cancer metastasis | Shirasaki |
||
- Significantly expressed highly in female pituitary tumors patients | |||
- Regulation of cell cycle and promotion of DNA repair | Wang |
||
- Higher expression in female colon cancer patients | |||
- Promotion of tumor cell proliferation and metastasis | De Rienzo |
||
- Significant reduction in survival of the entire cohort and across gender subgroups | |||
- Regulation of mRNA splicing | Graveley, 2000; Zhang |
||
- Higher expression significantly correlated with sex specific to male HCC patients |